Attached files
file | filename |
---|---|
S-1 - Talon Therapeutics, Inc. | v164071_s1.htm |
EX-4.9 - Talon Therapeutics, Inc. | v164071_ex4-9.htm |
EX-4.8 - Talon Therapeutics, Inc. | v164071_ex4-8.htm |
EX-4.11 - Talon Therapeutics, Inc. | v164071_ex4-11.htm |
EX-4.10 - Talon Therapeutics, Inc. | v164071_ex4-10.htm |
EX-5.1 - Talon Therapeutics, Inc. | v164071_ex5-1.htm |
Exhibit
23.1
Consent
of Independent Registered Public Accounting Firm
Hana
Biosciences, Inc.
South San
Francisco, California
We hereby
consent to the use in the Prospectus constituting a part of this Registration
Statement of our report dated March 30, 2009, relating to the financial
statements of Hana Biosciences, Inc., which is contained in that Prospectus. Our
report contains an explanatory paragraph regarding the Company’s ability to
continue as a going concern.
We also
consent to the reference to us under the caption “Experts” in the
Prospectus.
/s/ BDO
SEIDMAN, LLP
San
Francisco, California
October
30, 2009